Background Burn scar and alopecia on hair bearing area can severely affect social life of the patients. Unlike healthy skin, poor biological and mechanical properties of scar tissue in the recipient area can reduce survival rate of hair graft following hair transplantation. Objectives Combined non-ablative fractional laser (NAFL) and microfat injection could improve survival rate of hair grafts on post burn scar. Methods Thirteen patients with alopecia resulting from burn scar in hair bearing area of the scalp and face were treated with combined NAFL and microfat graft and subsequently follicular unit extraction (FUE) hair transplantation. Cicatricial alopecia occurred on the scalp, eyebrow, mustache, and beard areas. Patients were treated with 3-6 sessions of NAFL, and-2-5 sessions of microfat graft injections, followed by one session of hair transplantation using FUE technique. Results Hair transplantation was successfully performed with good to excellent results. The survival rate of transplanted follicular units ranged from 76 to 95 percent (mean, 85.04%) and the density success rate per square centimeter ranged from 76.9 to 95.2 percent (mean, 84.54%). All patients expressed high satisfaction with the results and no complication was encountered. Conclusions Hair transplantation, after combined NAFL and microfat injection is a promising treatment for post burn alopecia.

No abstract

Amaç: Tiroid hastalıkları sıklıkla saç, deri ve tırnaklarda çeşitli bulgulara neden olur. Bu bulguların bazıları tiroid hastalığının tedavisi ile gerileyebilir. Bu çalışmada tedavi altındaki tiroid hastalarında deri bulgularını değerlendirmeyi amaçladık. Gereç ve Yöntem: Bu kesitsel çalışmaya tedavi altındaki 97 tiroid hastası ve 50 sağlıklı kontrol dahil edildi. Tiroid hastalığı otoimmün ve nonotoimmün olarak sınıflandırıldı. Tüm deri bulguları ve dermatolojik hastalıklar kaydedildi. Bulgular: Hasta grubunun 56'sında (%57,7) otoimmün, 41'inde (%43,3) non-otoimmün tiroid hastalığı mevcuttu. Seksen dört (%86,4) hasta tiroid hormon tedavisi, 13 (%23,6) hasta anti-tiroid tedavi alıyordu. Otoimmün grubun %73,2'sinde, non-otoimmün grubun %71,4'ünde ve kontrol grubunun %52'sinde en az bir deri bulgusu vardı (p=0,05). Kseroz (p=0,026), kaşıntı (p=0,00), fasiyal eritem (p=0,036), flushing (p=0,004), kuru saç (p=0,008), kırılgan tırnaklar (p=0,02), kuru tırnaklar (p=0,013) ve tırnaklarda uzunlamasına çizgiler (p=0,02) otoimmün grupta non-otoimmün ve kontrol grubuna göre daha sıktı. Alopesi (p=0,00) non-otoimmün grupta daha sıktı. Ayrıca, hasta grubunda diffüz hiperhidroz (p=0,016), tırnaklarda incelme (p=0,059) ve rozase hastalığı (p=0,03) kontrol grubundan daha sıktı. Tiroid hormon tedavisi alanlarda, en az bir deri bulgusu, kserozis ve çeşitli tırnak bulguları anti-tiroid tedavi alanlara göre daha sıktı. Ancak istatistiksel olarak anlamlı bir fark yoktu. Background and Design: Thyroid diseases often cause various findings in hair, skin and nails. Some of them may be regressed by the treatment of thyroid disease. We aimed to evaluate the cutaneous manifestations in patients with thyroid disease under treatment. Materials and Methods: This cross-sectional study included 97 consecutive patients with thyroid disease under treatment and 50 healthy controls. Thyroid disease was classiffied as autoimmune and non-autoimmune. All skin findings and dermatological diseases were recorded. Results: Of the patient group, 56 (57.7%) had autoimmune, 41 (43.3%) had non-autoimmune thyroid disease. Eighty-four (86.4%) patients were under thyroid hormone therapy and 13 (23.6%) patients were under anti-thyroid therapy. 73.2% of the autoimmune group, 71.4% of non-autoimmune group and 52% of the control group had at least one cutaneous manifestation (p=0.05). Xerosis (p=0.026), pruritus (p=0.00), facial erythema (p=0.036), flushing (p=0.004), dry hair (p=0.008), brittle nails (p=0.02), dry nails (p=0.013) and longitudinal streaking on nails (p=0.02) were more frequent in the autoimmune group than in the non-autoimmune and control group. Alopecia (p=0.00) was more frequent in the non-autoimmune group. Furthermore diffuse hyperhidrosis (p=0.016), thinning of nails (p=0.059) and rosacea disease (p=0.03) were more common in the patient group than in the control group. At least one cutaneous manifestation, xerosis and various nail findings were more common in patients under thyroid hormone therapy than in patients under anti-thyroid therapy, but t...

Background Anxiety sensitivity (AS) is a continuous fundamental fear and defined as extreme fear of anxiety sensations and symptoms. High AS can cause tendency to anxiety disorders. There are many studies evaluating the anxiety in patients with acne; however, AS has not been investigated. Objective We aimed to investigate AS in patients with acne. Methods Two hundred and fourteen acne patients and 117 healthy control subjects, aged older than 16 years were enrolled in the study. Severity of acne was evaluated by Global Acne Grading System. The acne patients and healthy controls were asked to complete the anxiety sensitivity index-3 (ASI-3), the Beck anxiety inventory (BAI) and the Turkish version of acne quality of life index. Results Anxiety and AS levels in acne patients were significantly higher than healthy controls ( p <0.001). Quality of life was impaired in acne patients. Quality of life was negatively correlated with anxiety and AS levels in acne patients ( p =0.014, p =0.019, respectively). There was no correlation between quality of life and disease severity ( p =0.556) and also there was no correlation between psychiatric scale scores (ASI-3, BAI) and disease severity ( p =0.147, p =0.871, respectively). Conclusion To our knowledge, our study is the first to report that AS is high in acne patients. Clinically, our results suggest that there might be a relationship between AS and acne. We conclude that further studies are needed in order to clarify the relationship between acne and AS and to investigate the efficacy of cognitive behavioral treatments in acne patients.

Background:The rate of cosmetic procedures and use of skincare products is considered to be affected during the pandemic period; however, this has not been investigated yet.Objective: To determine whether the ongoing pandemic has changed people's habits related to skincare products and cosmetic procedures. Methods:We conducted a multicenter survey study covering both private and public hospitals. Sociodemographic characteristics and clinical diagnoses of the patients were noted by dermatologists. A survey was used to determine the type and application areas of skincare products and cosmetic procedures before and during the pandemic, whether the patients were concerned about being infected, and any change in the make-up habits of female patients.Results: Of the 1437 patients, 86.7% presented to the hospital due to dermatological complaints and 13.3% for cosmetic procedures. The rate of those that did not use skincare products was 0.05% before and 0.06% during the pandemic. Of the participants, 43.2% had undergone cosmetic procedures before and 38.1% during the pandemic.For both periods, the most frequent cosmetic procedure applied was laser epilation, followed by skincare treatment and chemical peeling. While undergoing these procedures, 34.9% of the patients were concerned about contracting coronavirus. Conclusion:There was no significant difference in the use of skincare products and cosmetic procedures before and during the pandemic. The majority of the patients continued to undergo these procedures despite their fear of being infected. This